COVID-19 Key EU Developments, Policy & Regulatory Update No. 29

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.

Explore Firm Details

This regular update (no. 29 | 15 December 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls;

United States Coronavirus (COVID-19)

Kaarli H. Eichhorn,Cristiana Spontoni, and Jörg Hladjk

Your Author LinkedIn Connections

Article Insights

Kaarli H. Eichhorn’s articles from Jones Day are most popular:

with Inhouse Counsel

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

European Court of Auditors reviews risks, challenges and opportunities in the EU's economic policy response to the COVID-19 crisis
EU approves new and amended Member State measures to support the economy

Trade / Export Controls

No noteworthy developments for this issue

Medicines, Medical Devices, and Personal Protective Equipment

European medicines agencies network presents Strategy to 2025
EMA further expands transparency in relation to COVID-19 medicinal products
EMA commences evaluation for granting marketing authorizations for two COVID-19 vaccines
EMA starts rolling review of COVID-19 vaccine

Cybersecurity, Privacy & Data Protection

No noteworthy developments for this issue

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Authors